HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Clinical trial NCT02143830 · RECRUITING

Trial details

NCT number: NCT02143830
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Fanconi Anemia Severe Marrow Failure Myelodysplastic Syndrome (MDS)Acute Myelogenous Leukemia (AML)

Start date: 2014-04-01
Primary completion: 2026-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.